Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. Gregory Paul Winter ( Reino Unido, 14 de abril de 1951) es un biólogo británico, investigador puntero en anticuerpos e inmunología humana. Estudió ciencias naturales en el Trinity College (Cambridge), doctorándose en ciencias de la mutación genética en el año de 1977.

  2. Sir Gregory Paul Winter CBE FRS FMedSci (born 14 April 1951) is a Nobel Prize-winning English molecular biologist best known for his work on the therapeutic use of monoclonal antibodies. His research career has been based almost entirely at the MRC Laboratory of Molecular Biology and the MRC Centre for Protein Engineering , in ...

  3. Gregory Winter. (14/04/1951 - ) Bioquímico británico. Premio Nobel de Química 2018. Campo: Bioquímica. Reconocido por: Ingeniería de anticuerpos. Nombre: Sir Gregory Paul Winter - Gregory P. Winter. Gregory Winter nació el 14 de abril de 1951 en Leicester, Reino Unido. Se crio en África occidental. Estudios.

  4. Sir Gregory P. Winter The Nobel Prize in Chemistry 2018. Born: 14 April 1951, Leicester, United Kingdom. Affiliation at the time of the award: MRC Laboratory of Molecular Biology, Cambridge, United Kingdom. Prize motivation: “for the phage display of peptides and antibodies” Prize share: 1/4. Life.

  5. 7 de oct. de 2018 · Sir Gregory Winter investigador del Laboratorio de Biología Molecular (LMB, del inglés Laboratory of Molecular Biology) del Medical Research Council (MRC) de Cambridge, Reino Unido, ha sido...

  6. MRC Laboratory of Molecular Biology, 1970. Credit: MRC Laboratory of Molecular Biology. Enzymes. I started my PhD studies at the MRC Laboratory of Molecular Biology, Cambridge (LMB) in the autumn of 1973, funded by an MRC studentship and supervised by Brian Hartley, a protein chemist.

  7. 3 de oct. de 2018 · Sir Greg Winter, of the University of Cambridge, has been jointly awarded the 2018 Nobel Prize in Chemistry, along with Frances Arnold and George Smith, for his pioneering work in using phage display for the directed evolution of antibodies, with the aim of producing new pharmaceuticals.